Clearwater France has advised MBO Partenaires on the acquisition of BCF Life Sciences.
MBO Partenaires takes over from Céréa Capital and Sodero Gestion, which acquired BCF Life Sciences in 2012, and will give the management (which reinvests to strengthen its majority) the financial resources and the human support necessary for the further development of the Group.
Based in Pleucadeuc (Morbihan), BCF Life Sciences is a leader of amino acids extraction by producing and selling 3 product ranges:
- L-Cystine and L-Tyrosine, amino acids primarily used in infant nutrition, food supplements and clinical nutrition;
- Carbocistéine, mucoregulatory active pharmaceutical ingredient;
- Free amino acid mix intended for animal nutrition (especially veterinary dietary products for dogs and cats, aquaculture) and vegetable (foliar biostimulants).
The Group’s turnover was €30m in 2017 and more than 60% of its activity abroad.
Since 2012, the Group's economic performance has been considerably increased, notably thanks to the commercial success of free amino acid powders. To support its growth, the Group invested €8m in a drying tower in 2015.
